British Journal of Haematology · 1999 · 72 citations · 22 references
MedicineHematologyMolecular BiologyCancer GeneticsHematologic OncologyMolecular OncologyCancer BiomarkersHematologic Malignancy TherapyAcute LeukemiasAcute Myeloid Leukemia BiologyBcr-abl1 Fusion GeneLeukemia DiagnosticsLeukemia-associated Fusion GenesMethod Detection LimitMyeloid BiomarkersMyeloid-derived Suppressor Cell Biomarkers
AML1/MTG8 was quantified relative to the expression of the GAPDH housekeeping gene by real-time RT-PCR in 22 patients with t(8;21)-positive acute myeloblastic leukaemia (AML) at initial diagnosis and in seven of these patients also during/after chemotherapy and allogeneic bone marrow transplantation. Real-time PCR was able to specifically detect and quantify AML1/MTG8 over a 5 log range. The detection limit for t(8;21)-positive cells was a dilution of 1:105. The AML1/MTG8 expression varied considerably among the 22 AML patients at intial diagnosis with a ratio AML1/MTG8:GAPDH of 0.5135+/-0.536 (range 0.1-2.14, median 0.318). In six patients with t(8;21)-positive AML a marked decline of AML1/MTG8 could be induced by chemotherapy. These patients are in ongoing complete haematological remission (CR) with a constant low-level AML1/MTG8 expression. In another patient a rapid rise of AML1/MTG8 transcripts could be detected in CR after allogeneic bone marrow transplantation and the patient relapsed 10 weeks later. In conclusion, real-time RT-PCR is a suitable approach for the quantification of AML1/MTG8 transcripts in the monitoring of AML patients with t(8;21) during/after chemotherapy and can provide data of prognostic relevance.
22
Chris Heid, Junko Stevens, Kenneth J. Livak et al. · Genome Research · 1996 · 6.2K citations · Full text
A novel method for real time quantitative RT-PCR.
U E Gibson, Chris Heid, P. Mickey Williams · Genome Research · 1996 · 2.1K citations · Full text